Suppr超能文献

先天性甲状腺功能减退症中国患者的基因突变筛查和功能研究。

Mutation Screening and Functional Study of in Chinese Patients with Congenital Hypothyroidism.

机构信息

The Core Laboratory in Medical Center of Clinical Research, Department of Endocrinology, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China

出版信息

J Clin Res Pediatr Endocrinol. 2022 Mar 3;14(1):46-55. doi: 10.4274/jcrpe.galenos.2021.2021.0122. Epub 2021 Sep 21.

Abstract

OBJECTIVE

Defects in the human solute carrier family 26 member 4 () gene are reported to be one of the causes of congenital hypothyroidism (CH). We aimed to identify mutations in Chinese patients with CH and analyze the function of the mutations.

METHODS

Patients with primary CH were screened for 21 CH candidate genes mutations by targeted next-generation sequencing. All the exons and exon-intron boundaries of were identified and analyzed. The function of six missense mutation in were further investigated .

RESULTS

Among 273 patients with CH, seven distinct heterozygous mutations (p.S49R, p.I363L, p.R409H, p.T485M, p.D661E, p.H723R, c.919-2A>G) were identified in 10 patients (3.66%, 10/273). In vitro experiments showed that mutation p.I363L, p.R409H, p.H723R affect the membrane location and ion transport of , while p.S49R did not. Mutation p.T485M and p.D661E only affected ion transport, but had no effect on the membrane location.

CONCLUSION

The prevalence of mutations was 3.66% in Chinese patients with CH. Five mutations (p.I363L, p.R409H, p.T485M, p.D661E and p.H723R) impaired the membrane location or ion transport function of , suggesting important roles for Ile363, Arg409, Thr485, Asp661, and His723 residues in function. As all variants identified were heterozygous, the pathogenesis of these patients cannot be explained, and the pathogenesis of these patients needs further study.

摘要

目的

据报道,人类溶质载体家族 26 成员 4()基因的缺陷是先天性甲状腺功能减退症(CH)的原因之一。我们旨在鉴定中国 CH 患者中的突变,并分析突变的功能。

方法

通过靶向下一代测序筛选 21 个 CH 候选基因的突变,鉴定并分析所有外显子和外显子-内含子边界。进一步研究了 6 个错义突变在中的功能。

结果

在 273 例 CH 患者中,在 10 例患者(3.66%,10/273)中发现了 7 个不同的杂合 突变(p.S49R、p.I363L、p.R409H、p.T485M、p.D661E、p.H723R、c.919-2A>G)。体外实验表明,突变 p.I363L、p.R409H、p.H723R 影响的膜定位和离子转运,而 p.S49R 没有。突变 p.T485M 和 p.D661E 仅影响离子转运,但对膜定位没有影响。

结论

中国 CH 患者的突变率为 3.66%。5 个突变(p.I363L、p.R409H、p.T485M、p.D661E 和 p.H723R)损害了的膜定位或离子转运功能,提示 Ile363、Arg409、Thr485、Asp661 和 His723 残基在中的功能中起着重要作用。由于所有鉴定的变体均为杂合子,因此这些患者的发病机制无法解释,这些患者的发病机制需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cddc/8900076/9f66b9f4fe2f/JCRPE-14-46-g2.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验